Project Details
Description
IL-15 Superagonist ALT-803 for Treatment of Advanced Staged Ovarian Cancer
Status | Finished |
---|---|
Effective start/end date | 7/17/17 → 7/31/20 |
Funding
- MN OVARIAN CANCER ALLIANCE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.